Tempe, AZNCT07919678Now EnrollingIRB Ready

Obesity Clinical Trial in Tempe, AZ

Access cutting-edge obesity treatment through this phase 3 clinical trial at a research site in Tempe. Study-provided care at no cost to qualified participants.

Sponsored by Pfizer

Quick Self-Assessment

See if you qualify for this Tempe location

Preparing your pre-screening questions…

Expert Care in Tempe

Access obesity specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity treatment provided free

Apply for This Tempe Location

Check if you qualify for this obesity clinical trial in Tempe, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tempe

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tempe site if eligible
  4. 4Begin participation

About This Obesity Study in Tempe

The purpose of this clinical study is to learn about the safety and effects of berobenatide (PF-08653944) for the treatment of knee osteoarthritis in adults with overweight or obesity. The study will last 52 weeks and compare the effects of berobenatide compared to placebo on knee pain, physical function, and body weight. Study activities will include blood tests, knee pain assessment, physical function questionnaires and body measurements.

Sponsor: Pfizer

Who Can Participate

Inclusion Criteria

Adults 18 years of age or older, or the minimum age of consent according to local regulations.
Body mass index of at least 27 kg/m² at Screening.
Currently meets American College of Rheumatology (ACR) Criteria for knee OA.
Pain due to knee OA.
Knee radiograph consistent with knee osteoarthritis and Kellgren-Lawrence Grade 2 or 3.
Willingness to complete the required analgesic washout.
History of at least 1 self-reported unsuccessful dietary effort to lose body weight.

Exclusion Criteria

Self-reported body weight increase or decrease greater than 5% within 90 days before Screening.
History of diabetes or Screening laboratory findings indicative of diabetes.
Known clinically significant gastric-emptying abnormality, history of acute or chronic pancreatitis, or active symptomatic gallbladder disease.
Personal history or first-degree family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.
Significant active or unstable psychiatric disorder.
Condition or knee disorder that could confound assessment of target-knee pain.
Prior target-knee replacement, planned target-knee replacement, or planned elective knee surgery during the study.
Recent use of weight-loss medication, any glucose-lowering therapy, or other protocol-prohibited treatment.
Prior participation in a berobenatide clinical trial with receipt of active treatment or placebo.
Hypersensitivity to a drug with glucagon-like peptide-1 receptor activity, including berobenatide, or any excipient.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tempe?

Yes, this clinical trial (NCT07919678) has an active research site in Tempe, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity Treatment Options in Tempe, AZ

If you're searching for obesity treatment options in Tempe, AZ, this clinical trial (NCT07919678) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tempe research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Tempe, AZ

See all obesity clinical trials recruiting in Tempe — not just this study.

Browse Obesity Trials in Tempe →

Browse More Trials by Condition

Obesity TrialsPediatric Obesity TrialsObesity Hypoventilation Syndrome TrialsAll Conditions →

Ready to Join in Tempe?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tempe, AZ